(Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept).
(Reporting by Abinaya Vijayaraghavan; Editing by Rashmi Aich)
Did you find this insightful?
Bad
Just Okay
Amazing